Obesity and survival in a cohort of predominantly hispanic children with acute lymphoblastic leukemia

Jacques Baillargeon, Anne Marie Langevin, Margaret Lewis, Jaime Estrada, Judith Mullins, Aaron Pitney, Jennie Z. Ma, Gary B. Chisholm, Brad H. Pollock

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Acute lymphoblastic leukemia (ALL), the most common malignancy in children, constitutes 25% of all pediatric cancer. Childhood cancer patients who are obese at diagnosis represent a particular challenge for the oncologist. Obesity may complicate chemotherapy dose determination, and has been associated with decreased overall and event-free survival in a number of adult cancer patients, and more recently in pediatric patients. The purpose of the present study was to examine whether obesity at diagnosis was associated with decreased overall and event-free survival in a cohort of 322 predominantly Hispanic pediatric patients with B-precursor ALL. Obesity was classified as an age-standardized and sex-standardized body mass index z-score at or above the 95th percentile. Hazard ratios (HRs) for overall and event-free survival were assessed using Cox proportional hazards regression modeling. Obesity at diagnosis was not associated with decreased overall survival (HR=1.40, 95% confidence interval=0.69-2.87) or event-free survival (HR=1.08, 95% confidence interval=0.65-1.82) in the overall cohort or in either of the 2 age-at-diagnosis (2 to 9 y; 10 to 18 y) subgroups. Our finding of no obesity-related prognostic effect in the overall cohort and in the under 2 to 9-year age-at-diagnosis cohort was consistent with the previous large-scale study of ALL patients; the absence of a prognostic effect in the 10 to 18-year age-at-diagnosis cohort, however, conflicted with previous findings.

Original languageEnglish (US)
Pages (from-to)575-578
Number of pages4
JournalJournal of Pediatric Hematology/Oncology
Volume28
Issue number9
DOIs
StatePublished - Sep 2006
Externally publishedYes

Fingerprint

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Hispanic Americans
Obesity
Disease-Free Survival
Survival
Pediatrics
Neoplasms
Confidence Intervals
Body Mass Index
Drug Therapy

Keywords

  • Acute lymphoblastic leukemia
  • Body mass index
  • Cancer risk
  • Hispanic
  • Obesity

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Hematology

Cite this

Obesity and survival in a cohort of predominantly hispanic children with acute lymphoblastic leukemia. / Baillargeon, Jacques; Langevin, Anne Marie; Lewis, Margaret; Estrada, Jaime; Mullins, Judith; Pitney, Aaron; Ma, Jennie Z.; Chisholm, Gary B.; Pollock, Brad H.

In: Journal of Pediatric Hematology/Oncology, Vol. 28, No. 9, 09.2006, p. 575-578.

Research output: Contribution to journalArticle

Baillargeon, J, Langevin, AM, Lewis, M, Estrada, J, Mullins, J, Pitney, A, Ma, JZ, Chisholm, GB & Pollock, BH 2006, 'Obesity and survival in a cohort of predominantly hispanic children with acute lymphoblastic leukemia', Journal of Pediatric Hematology/Oncology, vol. 28, no. 9, pp. 575-578. https://doi.org/10.1097/01.mph.0000212985.33941.d8
Baillargeon, Jacques ; Langevin, Anne Marie ; Lewis, Margaret ; Estrada, Jaime ; Mullins, Judith ; Pitney, Aaron ; Ma, Jennie Z. ; Chisholm, Gary B. ; Pollock, Brad H. / Obesity and survival in a cohort of predominantly hispanic children with acute lymphoblastic leukemia. In: Journal of Pediatric Hematology/Oncology. 2006 ; Vol. 28, No. 9. pp. 575-578.
@article{27cc9016e19647c6aae34194debf4716,
title = "Obesity and survival in a cohort of predominantly hispanic children with acute lymphoblastic leukemia",
abstract = "Acute lymphoblastic leukemia (ALL), the most common malignancy in children, constitutes 25{\%} of all pediatric cancer. Childhood cancer patients who are obese at diagnosis represent a particular challenge for the oncologist. Obesity may complicate chemotherapy dose determination, and has been associated with decreased overall and event-free survival in a number of adult cancer patients, and more recently in pediatric patients. The purpose of the present study was to examine whether obesity at diagnosis was associated with decreased overall and event-free survival in a cohort of 322 predominantly Hispanic pediatric patients with B-precursor ALL. Obesity was classified as an age-standardized and sex-standardized body mass index z-score at or above the 95th percentile. Hazard ratios (HRs) for overall and event-free survival were assessed using Cox proportional hazards regression modeling. Obesity at diagnosis was not associated with decreased overall survival (HR=1.40, 95{\%} confidence interval=0.69-2.87) or event-free survival (HR=1.08, 95{\%} confidence interval=0.65-1.82) in the overall cohort or in either of the 2 age-at-diagnosis (2 to 9 y; 10 to 18 y) subgroups. Our finding of no obesity-related prognostic effect in the overall cohort and in the under 2 to 9-year age-at-diagnosis cohort was consistent with the previous large-scale study of ALL patients; the absence of a prognostic effect in the 10 to 18-year age-at-diagnosis cohort, however, conflicted with previous findings.",
keywords = "Acute lymphoblastic leukemia, Body mass index, Cancer risk, Hispanic, Obesity",
author = "Jacques Baillargeon and Langevin, {Anne Marie} and Margaret Lewis and Jaime Estrada and Judith Mullins and Aaron Pitney and Ma, {Jennie Z.} and Chisholm, {Gary B.} and Pollock, {Brad H.}",
year = "2006",
month = "9",
doi = "10.1097/01.mph.0000212985.33941.d8",
language = "English (US)",
volume = "28",
pages = "575--578",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Obesity and survival in a cohort of predominantly hispanic children with acute lymphoblastic leukemia

AU - Baillargeon, Jacques

AU - Langevin, Anne Marie

AU - Lewis, Margaret

AU - Estrada, Jaime

AU - Mullins, Judith

AU - Pitney, Aaron

AU - Ma, Jennie Z.

AU - Chisholm, Gary B.

AU - Pollock, Brad H.

PY - 2006/9

Y1 - 2006/9

N2 - Acute lymphoblastic leukemia (ALL), the most common malignancy in children, constitutes 25% of all pediatric cancer. Childhood cancer patients who are obese at diagnosis represent a particular challenge for the oncologist. Obesity may complicate chemotherapy dose determination, and has been associated with decreased overall and event-free survival in a number of adult cancer patients, and more recently in pediatric patients. The purpose of the present study was to examine whether obesity at diagnosis was associated with decreased overall and event-free survival in a cohort of 322 predominantly Hispanic pediatric patients with B-precursor ALL. Obesity was classified as an age-standardized and sex-standardized body mass index z-score at or above the 95th percentile. Hazard ratios (HRs) for overall and event-free survival were assessed using Cox proportional hazards regression modeling. Obesity at diagnosis was not associated with decreased overall survival (HR=1.40, 95% confidence interval=0.69-2.87) or event-free survival (HR=1.08, 95% confidence interval=0.65-1.82) in the overall cohort or in either of the 2 age-at-diagnosis (2 to 9 y; 10 to 18 y) subgroups. Our finding of no obesity-related prognostic effect in the overall cohort and in the under 2 to 9-year age-at-diagnosis cohort was consistent with the previous large-scale study of ALL patients; the absence of a prognostic effect in the 10 to 18-year age-at-diagnosis cohort, however, conflicted with previous findings.

AB - Acute lymphoblastic leukemia (ALL), the most common malignancy in children, constitutes 25% of all pediatric cancer. Childhood cancer patients who are obese at diagnosis represent a particular challenge for the oncologist. Obesity may complicate chemotherapy dose determination, and has been associated with decreased overall and event-free survival in a number of adult cancer patients, and more recently in pediatric patients. The purpose of the present study was to examine whether obesity at diagnosis was associated with decreased overall and event-free survival in a cohort of 322 predominantly Hispanic pediatric patients with B-precursor ALL. Obesity was classified as an age-standardized and sex-standardized body mass index z-score at or above the 95th percentile. Hazard ratios (HRs) for overall and event-free survival were assessed using Cox proportional hazards regression modeling. Obesity at diagnosis was not associated with decreased overall survival (HR=1.40, 95% confidence interval=0.69-2.87) or event-free survival (HR=1.08, 95% confidence interval=0.65-1.82) in the overall cohort or in either of the 2 age-at-diagnosis (2 to 9 y; 10 to 18 y) subgroups. Our finding of no obesity-related prognostic effect in the overall cohort and in the under 2 to 9-year age-at-diagnosis cohort was consistent with the previous large-scale study of ALL patients; the absence of a prognostic effect in the 10 to 18-year age-at-diagnosis cohort, however, conflicted with previous findings.

KW - Acute lymphoblastic leukemia

KW - Body mass index

KW - Cancer risk

KW - Hispanic

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=33749350772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749350772&partnerID=8YFLogxK

U2 - 10.1097/01.mph.0000212985.33941.d8

DO - 10.1097/01.mph.0000212985.33941.d8

M3 - Article

VL - 28

SP - 575

EP - 578

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 9

ER -